Cargando…

Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease

Cerebral cavernous malformation (CCM) or cavernoma is a major vascular disease of genetic origin, whose main phenotypes occur in the central nervous system, and is currently devoid of pharmacological therapeutic strategies. Cavernomas can remain asymptomatic during a lifetime or manifest with a wide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrelli, Andrea, Bozza, Annalisa, Ferraris, Chiara, Osella, Sara, Moglia, Andrea, Mioletti, Silvia, Battaglia, Luigi, Retta, Saverio Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953270/ https://www.ncbi.nlm.nih.gov/pubmed/36831015 http://dx.doi.org/10.3390/biomedicines11020480

Ejemplares similares

Multifunctional Platinum@BSA–Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation
por: De Luca, Elisa, et al.
Publicado: (2018)

Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations
por: Antognelli, Cinzia, et al.
Publicado: (2020)

Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM)
por: Benedetti, Valerio, et al.
Publicado: (2022)

Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events
por: Bianconi, Andrea, et al.
Publicado: (2022)

KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins
por: Cianfruglia, Laura, et al.
Publicado: (2019)

Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment
por: Dianzani, Chiara, et al.
Publicado: (2020)

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
por: Kar, Souvik, et al.
Publicado: (2023)

Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin
por: Retta, Saverio Francesco, et al.
Publicado: (2016)

Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
por: Monge, Chiara, et al.
Publicado: (2022)

Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
por: Perrelli, Andrea, et al.
Publicado: (2018)

KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
por: Antognelli, Cinzia, et al.
Publicado: (2018)

Defective autophagy is a key feature of cerebral cavernous malformations
por: Marchi, Saverio, et al.
Publicado: (2015)

Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies
por: Marchi, Saverio, et al.
Publicado: (2016)

Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma
por: Foglietta, Federica, et al.
Publicado: (2023)

Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1
por: Choquet, Hélène, et al.
Publicado: (2016)

A Spinal Cavernous Malformation in Multiple Cerebral Cavernous Venous Malformations Syndrome
por: Vangrinsven, Guillaume, et al.
Publicado: (2023)

The cerebral cavernous malformations proteins
por: Li, Xiaofeng, et al.
Publicado: (2015)

Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells
por: Finetti, Federica, et al.
Publicado: (2018)

Advances in the biology of cerebral cavernous malformations
por: Kivelev, Juri, et al.
Publicado: (2010)

Advances in the biology of cerebral cavernous malformations
por: Hauptman, Jason S., et al.
Publicado: (2010)

Unusual Presentation of Cerebral Cavernous Malformation
por: Kim, Won-Hyung, et al.
Publicado: (2015)

Postzygotic mosaicism in cerebral cavernous malformation
por: Rath, Matthias, et al.
Publicado: (2020)

Varying clinical presentations of familial cerebral cavernous malformations (CCMs) and spinal cord cavernous malformations (SCCMs)
por: Nicholas-Bublick, Selena, et al.
Publicado: (2015)

CCM3 and cerebral cavernous malformation disease
por: Wang, Kang, et al.
Publicado: (2019)

Recent advances in cerebral cavernous malformation research
por: Padarti, Akhil, et al.
Publicado: (2018)

Pregnancy Combined with Epilepsy and Cerebral Cavernous Malformation
por: Xu, Ya-Lan, et al.
Publicado: (2017)

Gamma Knife radiosurgery for cerebral cavernous malformation
por: Lee, Cheng-Chia, et al.
Publicado: (2019)

Cerebral Cavernous Malformations: The Importance of Cutaneous Manifestations
por: Vázquez-Osorio, Igor, et al.
Publicado: (2021)

Cervical Cord Hemorrhage in Cerebral Cavernous Malformations
por: Wang, Zhanjun, et al.
Publicado: (2021)

Tailored Treatment Options for Cerebral Cavernous Malformations
por: Hoffman, Jessa E., et al.
Publicado: (2022)

Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives
por: Tu, Tianqi, et al.
Publicado: (2022)

Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations
por: Globisch, Maria Ascencion, et al.
Publicado: (2022)

Role of pericytes in the development of cerebral cavernous malformations
por: Dai, Zifeng, et al.
Publicado: (2022)

Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation
por: Globisch, Maria A., et al.
Publicado: (2022)

Vitamin D Deficiency and the Risk of Cerebrovascular Disease
por: Kim, Hyun Ah, et al.
Publicado: (2020)

Giant cavernous malformations
por: Linsler, Stefan
Publicado: (2016)

Resection of Cavernous Malformations
por: Morcos, Jacques J., et al.
Publicado: (2019)

PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations
por: Cigoli, Maria Sole, et al.
Publicado: (2014)

Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress
por: Mastrocola, Raffaella, et al.
Publicado: (2022)

Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican
por: Hong, Courtney C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lt368c9nj098j5g5jclvofrdju